← Back to Search

Newly developed warnings with images for Tobacco Use

N/A
Waitlist Available
Led By Adam O Goldstein
Research Sponsored by UNC Lineberger Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 21 (post test)
Awards & highlights

Study Summary

This trial will assess if new warnings on LCCs are more effective than current FDA warnings to reduce smoking. Adult LCC users in the US will take part.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 21 (post test)
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 21 (post test) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
LCC quit attempts in past week
LCC quit intentions
Number of LCCs butted out in the past week
+5 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Newly developed warnings with imagesExperimental Treatment1 Intervention
Participants receive newly developed warnings intervention
Group II: FDA proposed text-only warningsExperimental Treatment1 Intervention
Participants receive FDA proposed text only warning intervention
Group III: Control group, no interventionActive Control1 Intervention
Participants do not receive an intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
FDA proposed text-only warnings at 30% size
2023
N/A
~1030
Newly developed warnings with images at 30% size
2023
N/A
~1030

Find a Location

Who is running the clinical trial?

UNC Lineberger Comprehensive Cancer CenterLead Sponsor
353 Previous Clinical Trials
89,384 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,717 Previous Clinical Trials
40,952,334 Total Patients Enrolled
16 Trials studying Tobacco Use
9,163 Patients Enrolled for Tobacco Use
Adam O GoldsteinPrincipal Investigatorthe University of North Carolina (UNC) Department of Family Medicine
~514 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top